Bayer defies critics with $62 billion Monsanto offer: Reuters

German drugs and crop chemicals group Bayer has offered to buy U.S. seeds company Monsanto for $62 billion in cash, defying criticism from some of its own shareholders in a bid to grab the top spot in a fast-consolidating farm supplies industry, Reuters News reported.

23 May 2016•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles